 Flutamide hormone-resistant prostatic cancer Flutamide times subjective response evaluable patients hormone-resistant prostatic cancer additional patients early progression decrease pre-treatment prostate specific antigen level patients finding improved survival Toxicity gastrointestinal permanent discontinuation flutamide patients Flutamide similar antiandrogens role management hormone-resistant prostatic cancer relief subjective symptoms important treatment goal improvement survival drug management hormone-resistant prostatic cancer phase studies effectiveness comparison expensive drugs